CoChat

Amyloid β-Induced Nerve Growth Factor Dysmetabolism in Alzheimer Disease

Open access
Bruno, Martin A., Leon, Wanda C., Fragoso, Gabriela, Mushynski, Walter E., Almazan, Guillermina, Cuello, A. Claudio · 2009 · Journal of Neuropathology & Experimental Neurology
Cited by 149

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

We previously reported that the precursor form of nerve growth factor (pro-NGF) and not mature NGF is liberated in the CNS in an activity-dependent manner, and that its maturation and degradation occur in the extracellular space by the coordinated action of proteases.Here, we present evidence of diminished conversion of pro-NGF to its mature form and of greater NGF degradation in Alzheimer disease (AD) brain samples compared with controls. These alterations of the NGF metabolic pathway likely resulted in the increased pro-NGF levels. The pro-NGF was largely in a peroxynitrited form in the AD samples. Intrahippocampal injection of amyloid-beta oligomers provoked similar upregulation of pro-NGF in naive rats that was accompanied by evidence of microglial activation (CD40), increased levels of inducible nitric oxide synthase, and increased activity of the NGF-degrading enzyme matrix metalloproteinase 9. The elevated inducible nitric oxide synthase provoked the generation of biologically inactive, peroxynitrite-modified pro-NGF in amyloid-beta oligomer-injected rats. These parameters were corrected by minocycline treatment. Minocycline also diminished altered matrix metalloproteinase 9, inducible nitric oxide synthase, and microglial activation (CD40); improved cognitive behavior; and normalized pro-NGF levels in a transgenic mouse AD model. The effects of amyloid-beta amyloid CNS burden on NGF metabolism may explain the paradoxical upregulation of pro-NGF in AD accompanied by atrophy of forebrain cholinergic neurons.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/nen.0b013e3181aed9e6

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 15 references

Cited by

See all 149

Metadata

Authors
Bruno, M. A., Leon, W. C., Fragoso, G., Mushynski, W. E., Almazan, G., & Cuello, A. C.
Venue
Journal of Neuropathology & Experimental Neurology
Published
2009-08
Volume
68
Issue
8
Pages
857-869
ISSN
  • 0022-3069 (ISSN-L)
  • 1554-6578
OpenAlex
W2036780475
Cited by
149
References
15
FWCI
4.92
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloid β-Induced Nerve Growth Factor Dysmetabolism in Alzheimer Disease. https://app.cochat.ai/papers/10.1097/nen.0b013e3181aed9e6
The paper
Bruno, M. A., Leon, W. C., Fragoso, G., Mushynski, W. E., Almazan, G., & Cuello, A. C. (2009). Amyloid β-Induced Nerve Growth Factor Dysmetabolism in Alzheimer Disease. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1097/nen.0b013e3181aed9e6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.